BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22998541)

  • 1. Cutaneous adverse events associated with heparin.
    Maldonado Cid P; Alonso de Celada RM; Noguera Morel L; Feito-Rodríguez M; Gómez-Fernández C; Herranz Pinto P
    Clin Exp Dermatol; 2012 Oct; 37(7):707-11. PubMed ID: 22998541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cutaneous type IV hypersensitivity reactions induced by heparin.
    Ludwig RJ; Schindewolf M; Utikal J; Lindhoff-Last E; Boehncke WH
    Thromb Haemost; 2006 Nov; 96(5):611-7. PubMed ID: 17080218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced skin lesions.
    Schindewolf M; Lindhoff-Last E; Ludwig RJ; Boehncke WH
    Lancet; 2012 Nov; 380(9856):1867-79. PubMed ID: 22642893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex clinical picture of side effects to anticoagulation.
    Trautmann A; Seitz CS
    Med Clin North Am; 2010 Jul; 94(4):821-34, xii-iii. PubMed ID: 20609865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin.
    Koch P; Hindi S; Landwehr D
    Contact Dermatitis; 1996 Feb; 34(2):156-8. PubMed ID: 8681559
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparins and skin reactions: from diagnostic to management].
    Barouti N; Masouyé I; Boehncke WH; Prins C
    Rev Med Suisse; 2013 Apr; 9(380):705-6, 708-11. PubMed ID: 23621039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed cutaneous reactions to heparin in antiphospholipid syndrome during pregnancy.
    Kim J; Smith KJ; Toner C; Skelton H
    Int J Dermatol; 2004 Apr; 43(4):252-60. PubMed ID: 15090006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed-type hypersensitivity to heparin with tolerance of its intravenous administration.
    Irion R; Gall H; Peter RU
    Contact Dermatitis; 2000 Oct; 43(4):249-50. PubMed ID: 11011948
    [No Abstract]   [Full Text] [Related]  

  • 9. Tolerance to intravenous heparin in patients with delayed-type hypersensitivity to heparins: a prospective study.
    Gaigl Z; Pfeuffer P; Raith P; Bröcker EB; Trautmann A
    Br J Haematol; 2005 Feb; 128(3):389-92. PubMed ID: 15667543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed systemic reactions with flare-ups of previously negative intradermal skin tests to heparin.
    García Robaina JC; Sánchez Machín I; Fernández-Caldas E; de la Torre Morín F
    Allergy; 2003 Jul; 58(7):685-6. PubMed ID: 12823138
    [No Abstract]   [Full Text] [Related]  

  • 11. Intolerance of fondaparinux in a patient allergic to heparins.
    Hirsch K; Ludwig RJ; Lindhoff-Last E; Kaufmann R; Boehncke WH
    Contact Dermatitis; 2004 Jun; 50(6):383-4. PubMed ID: 15274739
    [No Abstract]   [Full Text] [Related]  

  • 12. [Delayed-type hypersensitivity to heparin: diagnosis and therapeutic management].
    Nosbaum A; Pralong P; Rozieres A; Dargaud Y; Nicolas JF; Bérard F
    Ann Dermatol Venereol; 2012 May; 139(5):363-8. PubMed ID: 22578340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-induced skin necrosis and low molecular weight heparins.
    Drew PJ; Smith MJ; Milling MA
    Ann R Coll Surg Engl; 1999 Jul; 81(4):266-9. PubMed ID: 10615196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An approach to heparin and lidocaine hypersensitivity for the interventional nephrologist.
    Sequeira A
    Semin Dial; 2014; 27(5):512-7. PubMed ID: 24397566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous reactions to anticoagulants. Recognition and management.
    Harenberg J; Hoffmann U; Huhle G; Winkler M; Bayerl C
    Am J Clin Dermatol; 2001; 2(2):69-75. PubMed ID: 11705306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux.
    Hohenstein E; Tsakiris D; Bircher AJ
    Contact Dermatitis; 2004 Sep; 51(3):149-51. PubMed ID: 15479206
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed hypersensitivity to enoxaparin.
    Cabañas R; Caballero MT; López-Serrano MC; Díaz R; Contreras J; Barranco P; Moreno-Ancillo A
    J Investig Allergol Clin Immunol; 1998; 8(6):383-4. PubMed ID: 10028487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia, paradoxical thromboembolism, and other side effects of heparin therapy.
    Walenga JM; Bick RL
    Med Clin North Am; 1998 May; 82(3):635-58. PubMed ID: 9646784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux.
    Koch P
    Contact Dermatitis; 2003 Dec; 49(6):276-80. PubMed ID: 15025697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous adverse drug reaction to heparins with hypereosinophilia and high IgE level.
    Klos K; Spiewak R; Kruszewski J; Bant A
    Contact Dermatitis; 2011 Jan; 64(1):61-2. PubMed ID: 21166821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.